- Home
- CNTX vs MPV Comparison
CNTX vs MPV Comparison
Compare CNTX & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTX | MPV |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.5M | 201.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTX | MPV |
|---|---|---|
| Price | $2.88 | $19.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 9.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.71% |
| EPS Growth | ★ 69.33 | N/A |
| EPS | N/A | ★ 1.71 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.94 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.49 | $15.16 |
| 52 Week High | $3.30 | $21.00 |
Technical Indicators
Market Signals| Indicator | CNTX | MPV |
|---|---|---|
| Relative Strength Index (RSI) | 65.86 | 54.92 |
| Support Level | $2.07 | $18.64 |
| Resistance Level | N/A | $19.54 |
| Average True Range (ATR) | 0.23 | 0.31 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 69.26 | 88.60 |
Price Performance
Historical ComparisonAbout CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.